Front cover image for Incidence of ethambutol-related visual impairment during treatment of active tuberculosis

Peer-reviewed

Incidence of ethambutol-related visual impairment during treatment of active tuberculosis

Recent World Health Organization guidelines recommend the addition of ethambutol (EMB) throughout standardised treatment of new cases of active tuberculosis (TB) in populations with increased prevalence of isoniazid resistance to reduce the risk of creating multidrug resistance. This could expose patients to the risk of blindness

Article, 2013